These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32946763)

  • 1. Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.
    Jones MR; Peng PC; Coetzee SG; Tyrer J; Reyes ALP; Corona RI; Davis B; Chen S; Dezem F; Seo JH; Kar S; Dareng E; ; Berman BP; Freedman ML; Plummer JT; Lawrenson K; Pharoah P; Hazelett DJ; Gayther SA
    Am J Hum Genet; 2020 Oct; 107(4):622-635. PubMed ID: 32946763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
    Dareng EO; Coetzee SG; Tyrer JP; Peng PC; Rosenow W; Chen S; Davis BD; Dezem FS; Seo JH; Nameki R; Reyes AL; Aben KKH; Anton-Culver H; Antonenkova NN; Aravantinos G; Bandera EV; Beane Freeman LE; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bolton KL; Brenton JD; Budzilowska A; Butzow R; Cai H; Campbell I; Cannioto R; Chang-Claude J; Chanock SJ; Chen K; Chenevix-Trench G; ; Chiew YE; Cook LS; DeFazio A; Dennis J; Doherty JA; Dörk T; du Bois A; Dürst M; Eccles DM; Ene G; Fasching PA; Flanagan JM; Fortner RT; Fostira F; Gentry-Maharaj A; Giles GG; Goodman MT; Gronwald J; Haiman CA; Håkansson N; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Huang RY; Jensen A; Jones ME; Kang D; Karlan BY; Karnezis AN; Kelemen LE; Kennedy CJ; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Larson MC; Le ND; Lester J; Li L; Lubiński J; Lush M; Marks JR; Matsuo K; May T; McLaughlin JR; McNeish IA; Menon U; Missmer S; Modugno F; Moffitt M; Monteiro AN; Moysich KB; Narod SA; Nguyen-Dumont T; Odunsi K; Olsson H; Onland-Moret NC; Park SK; Pejovic T; Permuth JB; Piskorz A; Prokofyeva D; Riggan MJ; Risch HA; Rodríguez-Antona C; Rossing MA; Sandler DP; Setiawan VW; Shan K; Song H; Southey MC; Steed H; Sutphen R; Swerdlow AJ; Teo SH; Terry KL; Thompson PJ; Vestrheim Thomsen LC; Titus L; Trabert B; Travis R; Tworoger SS; Valen E; Van Nieuwenhuysen E; Edwards DV; Vierkant RA; Webb PM; ; Weinberg CR; Weise RM; Wentzensen N; White E; Winham SJ; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Zeinomar N; Zheng W; Ziogas A; Berchuck A; Goode EL; Huntsman DG; Pearce CL; Ramus SJ; Sellers TA; ; Freedman ML; Lawrenson K; Schildkraut JM; Hazelett D; Plummer JT; Kar S; Jones MR; Pharoah PDP; Gayther SA
    Am J Hum Genet; 2024 Jun; 111(6):1061-1083. PubMed ID: 38723632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.
    Nakamura K; Reid BM; Chen A; Chen Z; Goode EL; Permuth JB; Teer JK; Tyrer J; Yu X; Kanetsky PA; Pharoah PD; Gayther SA; Sellers TA; Lawrenson K; Karreth FA
    Am J Hum Genet; 2022 Jan; 109(1):116-135. PubMed ID: 34965383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.
    Corona RI; Seo JH; Lin X; Hazelett DJ; Reddy J; Fonseca MAS; Abassi F; Lin YG; Mhawech-Fauceglia PY; Shah SP; Huntsman DG; Gusev A; Karlan BY; Berman BP; Freedman ML; Gayther SA; Lawrenson K
    Nat Commun; 2020 Apr; 11(1):2020. PubMed ID: 32332753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.
    Coetzee SG; Shen HC; Hazelett DJ; Lawrenson K; Kuchenbaecker K; Tyrer J; Rhie SK; Levanon K; Karst A; Drapkin R; Ramus SJ; ; Couch FJ; Offit K; Chenevix-Trench G; Monteiro AN; Antoniou A; Freedman M; Coetzee GA; Pharoah PD; Noushmehr H; Gayther SA;
    Hum Mol Genet; 2015 Jul; 24(13):3595-607. PubMed ID: 25804953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.
    DeVries AA; Dennis J; Tyrer JP; Peng PC; Coetzee SG; Reyes AL; Plummer JT; Davis BD; Chen SS; Dezem FS; Aben KKH; Anton-Culver H; Antonenkova NN; Beckmann MW; Beeghly-Fadiel A; Berchuck A; Bogdanova NV; Bogdanova-Markov N; Brenton JD; Butzow R; Campbell I; Chang-Claude J; Chenevix-Trench G; Cook LS; DeFazio A; Doherty JA; Dörk T; Eccles DM; Eliassen AH; Fasching PA; Fortner RT; Giles GG; Goode EL; Goodman MT; Gronwald J; ; ; Håkansson N; Hildebrandt MAT; Huff C; Huntsman DG; Jensen A; Kar S; Karlan BY; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Le ND; Lubiński J; May T; Menon U; Milne RL; Modugno F; Monteiro AN; Moysich KB; Odunsi K; Olsson H; Pearce CL; Pejovic T; Ramus SJ; Riboli E; Riggan MJ; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Sieh W; Song H; Sutphen R; Terry KL; Thompson PJ; Titus L; Tworoger SS; Van Nieuwenhuysen E; Edwards DV; Webb PM; Wentzensen N; Whittemore AS; Wolk A; Wu AH; Ziogas A; Freedman ML; Lawrenson K; Pharoah PDP; Easton DF; Gayther SA; Jones MR
    J Natl Cancer Inst; 2022 Nov; 114(11):1533-1544. PubMed ID: 36210504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.
    Buckley MA; Woods NT; Tyrer JP; Mendoza-Fandiño G; Lawrenson K; Hazelett DJ; Najafabadi HS; Gjyshi A; Carvalho RS; Lyra PC; Coetzee SG; Shen HC; Yang AW; Earp MA; Yoder SJ; Risch H; Chenevix-Trench G; Ramus SJ; Phelan CM; Coetzee GA; Noushmehr H; Hughes TR; Sellers TA; Goode EL; Pharoah PD; Gayther SA; Monteiro ANA;
    Cancer Res; 2019 Feb; 79(3):467-481. PubMed ID: 30487138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
    Lawrenson K; Iversen ES; Tyrer J; Weber RP; Concannon P; Hazelett DJ; Li Q; Marks JR; Berchuck A; Lee JM; Aben KK; Anton-Culver H; Antonenkova N; ; ; Bandera EV; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chenevix-Trench G; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Plisiecka-Halasa J; Dennis J; Dicks E; Doherty JA; Dörk T; du Bois A; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Gronwald J; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Jakubowska A; Paul J; Jensen A; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Lambrechts D; Lambrechts S; Le ND; Lee AW; Cannioto R; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Nevanlinna H; McNeish I; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Noor Azmi MA; Odunsi K; Olson SH; Orlow I; Orsulic S; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Phelan CM; Pike MC; Poole EM; Ramus SJ; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Budzilowska A; Sellers TA; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Sucheston L; Tangen IL; Teo SH; Terry KL; Thompson PJ; Timorek A; Tworoger SS; Van Nieuwenhuysen E; Vergote I; Vierkant RA; Wang-Gohrke S; Walsh C; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Woo YL; Wu X; Wu AH; Yang H; Zheng W; Ziogas A; Coetzee GA; Freedman ML; Monteiro AN; Moes-Sosnowska J; Kupryjanczyk J; Pharoah PD; Gayther SA; Schildkraut JM
    Carcinogenesis; 2015 Nov; 36(11):1341-53. PubMed ID: 26424751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk variants for brain disorders are enriched in cortical H3K27ac domains.
    Hannon E; Marzi SJ; Schalkwyk LS; Mill J
    Mol Brain; 2019 Jan; 12(1):7. PubMed ID: 30691483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically predicted circulating protein biomarkers and ovarian cancer risk.
    Considine DPC; Jia G; Shu X; Schildkraut JM; Pharoah PDP; Zheng W; Kar SP;
    Gynecol Oncol; 2021 Feb; 160(2):506-513. PubMed ID: 33246661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the identification of potential regulatory variants within genome wide association candidate SNP sets.
    Chen CY; Chang IS; Hsiung CA; Wasserman WW
    BMC Med Genomics; 2014 Jun; 7():34. PubMed ID: 24920305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions.
    Kar SP; Berchuck A; Gayther SA; Goode EL; Moysich KB; Pearce CL; Ramus SJ; Schildkraut JM; Sellers TA; Pharoah PDP
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):395-404. PubMed ID: 28615364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.
    Tansey KE; Cameron D; Hill MJ
    Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.
    Reid BM; Permuth JB; Chen YA; Teer JK; Monteiro AN; Chen Z; Tyrer J; Berchuck A; Chenevix-Trench G; Doherty JA; Goode EL; Iverson ES; Lawrenson K; Pearce CL; Pharoah PD; Phelan CM; Ramus SJ; Rossing MA; Schildkraut JM; Cheng JQ; Gayther SA; Sellers TA; ; ;
    Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):116-125. PubMed ID: 28035019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.
    Lu Y; Beeghly-Fadiel A; Wu L; Guo X; Li B; Schildkraut JM; Im HK; Chen YA; Permuth JB; Reid BM; Teer JK; Moysich KB; Andrulis IL; Anton-Culver H; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Benitez J; Bjorge L; Brenton J; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Claes KBM; Couch FJ; Cramer DW; Daly MB; deFazio A; Dennis J; Diez O; Domchek SM; Dörk T; Easton DF; Eccles DM; Fasching PA; Fortner RT; Fountzilas G; Friedman E; Ganz PA; Garber J; Giles GG; Godwin AK; Goldgar DE; Goodman MT; Greene MH; Gronwald J; Hamann U; Heitz F; Hildebrandt MAT; Høgdall CK; Hollestelle A; Hulick PJ; Huntsman DG; Imyanitov EN; Isaacs C; Jakubowska A; James P; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Kwong A; Le ND; Leslie G; Lesueur F; Levine DA; Mattiello A; May T; McGuffog L; McNeish IA; Merritt MA; Modugno F; Montagna M; Neuhausen SL; Nevanlinna H; Nielsen FC; Nikitina-Zake L; Nussbaum RL; Offit K; Olah E; Olopade OI; Olson SH; Olsson H; Osorio A; Park SK; Parsons MT; Peeters PHM; Pejovic T; Peterlongo P; Phelan CM; Pujana MA; Ramus SJ; Rennert G; Risch H; Rodriguez GC; Rodríguez-Antona C; Romieu I; Rookus MA; Rossing MA; Rzepecka IK; Sandler DP; Schmutzler RK; Setiawan VW; Sharma P; Sieh W; Simard J; Singer CF; Song H; Southey MC; Spurdle AB; Sutphen R; Swerdlow AJ; Teixeira MR; Teo SH; Thomassen M; Tischkowitz M; Toland AE; Trichopoulou A; Tung N; Tworoger SS; van Rensburg EJ; Vanderstichele A; Vega A; Edwards DV; Webb PM; Weitzel JN; Wentzensen N; White E; Wolk A; Wu AH; Yannoukakos D; Zorn KK; Gayther SA; Antoniou AC; Berchuck A; Goode EL; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
    Cancer Res; 2018 Sep; 78(18):5419-5430. PubMed ID: 30054336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A targeted genetic association study of epithelial ovarian cancer susceptibility.
    Earp M; Winham SJ; Larson N; Permuth JB; Sicotte H; Chien J; Anton-Culver H; Bandera EV; Berchuck A; Cook LS; Cramer D; Doherty JA; Goodman MT; Levine DA; Monteiro AN; Ness RB; Pearce CL; Rossing MA; Tworoger SS; Wentzensen N; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Cunningham JM; Edwards RP; Fogarty ZC; Iversen ES; Kraft P; Larson MC; Le ND; Lin HY; Lissowska J; Modugno F; Moysich KB; Olson SH; Pike MC; Poole EM; Rider DN; Terry KL; Thompson PJ; van den Berg D; Vierkant RA; Vitonis AF; Wilkens LR; Wu AH; Yang HP; Ziogas A; Phelan CM; Schildkraut JM; Chen YA; Sellers TA; Fridley BL; Goode EL
    Oncotarget; 2016 Feb; 7(7):7381-9. PubMed ID: 26848776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.
    French JD; Johnatty SE; Lu Y; Beesley J; Gao B; Kalimutho M; Henderson MJ; Russell AJ; Kar S; Chen X; Hillman KM; Kaufmann S; Sivakumaran H; O'Reilly M; Wang C; Korbie DJ; ; ; Lambrechts D; Despierre E; Van Nieuwenhuysen E; Lambrechts S; Vergote I; Karlan B; Lester J; Orsulic S; Walsh C; Fasching PA; Beckmann MW; Ekici AB; Hein A; Matsuo K; Hosono S; Pisterer J; Hillemanns P; Nakanishi T; Yatabe Y; Goodman MT; Lurie G; Matsuno RK; Thompson PJ; Pejovic T; Bean Y; Heitz F; Harter P; du Bois A; Schwaab I; Hogdall E; Kjaer SK; Jensen A; Hogdall C; Lundvall L; Engelholm SA; Brown B; Flanagan JM; Metcalf MD; Siddiqui N; Sellers T; Fridley B; Cunningham J; Schildkraut JM; Iversen E; Weber RP; Brennan D; Berchuck A; Pharoah P; Harnett P; Norris MD; Haber M; Goode EL; Lee JS; Khanna KK; Meyer KB; Chenevix-Trench G; deFazio A; Edwards SL; MacGregor S;
    Oncotarget; 2016 Feb; 7(6):6353-68. PubMed ID: 26840454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
    Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
    Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.
    Jung M; Gao J; Cheung L; Bongers A; Somers K; Clifton M; Ramsay EE; Russell AJ; Valli E; Gifford AJ; George J; Kennedy CJ; Wakefield MJ; Topp M; Ho GY; ; Scott CL; Bowtell DD; deFazio A; Norris MD; Haber M; Henderson MJ
    Int J Cancer; 2020 Oct; 147(8):2225-2238. PubMed ID: 32277480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variants at 19p13 are associated with susceptibility to ovarian cancer.
    Bolton KL; Tyrer J; Song H; Ramus SJ; Notaridou M; Jones C; Sher T; Gentry-Maharaj A; Wozniak E; Tsai YY; Weidhaas J; Paik D; Van Den Berg DJ; Stram DO; Pearce CL; Wu AH; Brewster W; Anton-Culver H; Ziogas A; Narod SA; Levine DA; Kaye SB; Brown R; Paul J; Flanagan J; Sieh W; McGuire V; Whittemore AS; Campbell I; Gore ME; Lissowska J; Yang HP; Medrek K; Gronwald J; Lubinski J; Jakubowska A; Le ND; Cook LS; Kelemen LE; Brooks-Wilson A; Massuger LF; Kiemeney LA; Aben KK; van Altena AM; Houlston R; Tomlinson I; Palmieri RT; Moorman PG; Schildkraut J; Iversen ES; Phelan C; Vierkant RA; Cunningham JM; Goode EL; Fridley BL; Kruger-Kjaer S; Blaeker J; Hogdall E; Hogdall C; Gross J; Karlan BY; Ness RB; Edwards RP; Odunsi K; Moyisch KB; Baker JA; Modugno F; Heikkinenen T; Butzow R; Nevanlinna H; Leminen A; Bogdanova N; Antonenkova N; Doerk T; Hillemanns P; Dürst M; Runnebaum I; Thompson PJ; Carney ME; Goodman MT; Lurie G; Wang-Gohrke S; Hein R; Chang-Claude J; Rossing MA; Cushing-Haugen KL; Doherty J; Chen C; Rafnar T; Besenbacher S; Sulem P; Stefansson K; Birrer MJ; Terry KL; Hernandez D; Cramer DW; Vergote I; Amant F; Lambrechts D; Despierre E; Fasching PA; Beckmann MW; Thiel FC; Ekici AB; Chen X; ; ; ; Johnatty SE; Webb PM; Beesley J; Chanock S; Garcia-Closas M; Sellers T; Easton DF; Berchuck A; Chenevix-Trench G; Pharoah PD; Gayther SA
    Nat Genet; 2010 Oct; 42(10):880-4. PubMed ID: 20852633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.